Venous Thrombosis in Women
eBook - ePub

Venous Thrombosis in Women

Pregnancy, the Contraceptive Pill and Hormone Replacement Therapy

  1. 112 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Venous Thrombosis in Women

Pregnancy, the Contraceptive Pill and Hormone Replacement Therapy

About this book

The impact of hormones on deep venous thrombosis is one of the most charged and debated subjects in contraceptive medicine. Female hormonal balance is primarily affected by the use of either oral contraceptives or HRT. For a long time it has been recognized that oral contraceptives can raise the incidence of DVT; however, there has been an enormous controversy as to whether all progestins do this equally or whether some have a greater impact than others where oral contraception is concerned. Written by a world leader on the subject, this book offers the latest clinical information about the effects of pregnancy, the contraceptive pill, and hormone replacement therapy on thrombotic problems in women.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere β€” even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Venous Thrombosis in Women by Ian A. Greer in PDF and/or ePUB format, as well as other popular books in Medicine & Cardiology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
CRC Press
Year
2003
eBook ISBN
9781135401399
Edition
1
Topic
Medicine
Subtopic
Cardiology

References

1. Ruggerri ZM, Dent JA, Saldivar E, etal.Contribution of distinct adhesion interactions to platelet aggregation in flowing blood. Blood 1999;94:172–8 flowing blood. Blood 1999;94:172–8
2. Tracy PB. Role of platelets and leukocytes and coagulation. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis andThrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:575–96
3. Morrissey JH. Tissue factor and factor VII initiation of coagulation. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:89–102
4. Colman RW, Clowes AW, George JN, et al. Overview of coagulation fibrinolysis and their regulation. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis and Thrombosis. BasicPrinciples and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:3–16
5. Bachman F. Plasminogen-plasmin enzyme system. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis andThrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:275–320
6. Stiko A, Hervio L, Loskautoff D. Plasminogen activator inhibitors. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Haemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:355–66
7. Robbie LA, Bennett B, Keyt BA, et al. Effective lysis of model thrombi by a t-PA mutant (A-473S) that is resistant to Ι‘2- antiplasmin. Br JHaematol 2000; 111:517–23 antiplasmin. Br JHaematol 2000; 111:517–23
8. Stirling Y, Woolf L, North WRS, et al. Haemostasis in normal pregnancy. Thromb Haemost 1984;52:176–82
9. Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I Normal condition. Gynaecol Obstet Invest 1981;12:141–54
10. Fay RA, Hughes AO, Farron NT. Platelets in pregnancy: hyperdestruction in pregnancy. Obstet Gynecol 1983;61:238–40
11. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988;319:142–5
12. Cadroy Y, Grandjean H, Pichon J, etal.Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993;100:416–20
13. Tygart SG, McRoyan DK, Spinnato JA, et al. Longitudinal study of platelet indices during normal pregnancy. Am J Obstet Gynecol 1986;154:883–7
14. Singer CRJ, Walker JJ, Cameron A, et al. Platelet studies in normal pregnancy and pregnancy induced hypertension. Clin Lab Haematol 1986;8:27–32
15. Gatti L, Tenconi PM, Guarneri D, et al. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res 1994;24:217–19
16. Morrison R, Crawford J, MacPherson M, et al. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thromb Haemostas 1985;54:607–11 hypertension. Thromb Haemostas 1985;54:607–11
17. Burgess-Wilson ME, Morrison R, Heptinstall S. Spontaneous platelet aggregation in heparinised blood during pregnancy. Thromb Res 1986;37:385–93 during pregnancy. Thromb Res 1986;37:385–93
18. Louden KA, Broughton-Pipkin F, Heptinstall S, et al. A longitudinal study of platelet behaviour and thromboxane production in whole blood in normal pregnancy and the puerperium. Br J Obstet Gynaecol 1990;97:1108–14
19. Norris LA, Sheppard BL, Bonnar J. Increased whole blood platelet aggregation in normal pregnancy can be prevented in vitro by aspirin and dezmegrel. Br J Obstet Gynaecol 1992; 99:253–7 20. Horn EH, Hardy E, Cooper J, et al. Platelet reactivity in vitro
20. Horn EH, Hardy E, Cooper J, et al. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Thromb Haemostas 1996;75:346–51
21. Horn EH, Cooper JA, Hardy E, et al.Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia. Clin Sci 1995;89:91–5
22. O’Brien WF, Saba HI, Knuppel RA, et al. Alterations in platelet concentration and aggregation in normal pregnancy and pre-eclampsia. Am J Obstet Gynecol 1986;155:486–9
23. Douglas JT, Shah M, Lowe GDO, etal.Plasma fibrinopeptide A and ß-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost 1982;47:54–5
24. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79: 1166–70
25. Persson BL, Stenberg P, Holmberg L, et al. Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterine growth retardation. J Dev Physiol 1980;2:37–41 retardation. J Dev Physiol 1980;2:37–41
26. Halligan A, Bonnar J, Sheppard B, et al. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br JObstet Gynaecol 1994;101:488–92
27. Eichinger S, Weltermann A, Philipp K, et al. Prospective evaluation of haemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999;82:1232–6
28. Holmes VA, Wallace JMW, Gilmore WS, et al. Tisssue factor expression on monocyte subpopulations during normal pregnancy. ThrombHaemost 2002;87:953–8
29. Comp PC, Thurneau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986;68:881–5
30. Bonnar J, McNicol GP, Douglas AS, et al. Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J1970;2:200–3
31. Booth N, Reith A, Bennett B, et al. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy. ThrombHaemost 1988;59:77–9
32. Lecander I, Astedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol 1986;62:221–8
33. Nil...

Table of contents

  1. Cover Page
  2. Title Page
  3. Copyright Page
  4. I: Overview of the hemostatic and fibrinolytic systems
  5. 2: Physiological changes inhemostasis and fibrinolysis in pregnancy
  6. 3: Venous thromboembolism in pregnancy
  7. 4: Venous thromboembolism and the oral contraceptive pill
  8. 5: Venous thromboembolism andhormone replacement therapy
  9. References